UNI MEDICAL (02666) announced its financial results for 2025. Revenue reached approximately RMB 14.9395 billion, representing a 9.3% year-on-year increase. Profit attributable to the company's ordinary shareholders was approximately RMB 2.1568 billion, a rise of 6.2% compared to the previous year. Basic earnings per share were RMB 1.13. A final dividend of HKD 0.36 per share for 2025 is proposed, with a dividend payout ratio of 30%.
In 2025, the integrated healthcare segment comprised 65 medical institutions, including 5 tertiary Grade A hospitals, 1 tertiary specialized hospital, and 30 secondary hospitals. These institutions collectively provided 15,628 open beds. The segment contributed reported revenue of RMB 8.183 billion, an increase of 7.5% year-on-year. However, profit for the year within this segment was RMB 287.4 million, a decrease of 39.3% compared to the previous year. This decline was primarily attributed to two factors: a reduction in average patient costs due to healthcare payment reforms, and increased depreciation, amortization, and personnel costs resulting from the operational scaling of new infrastructure projects.
Profit before tax grew by 3.9% year-on-year. This improvement was driven by steady operational gains in the healthcare business, achieved through acquisitions and internal enhancements in quality and efficiency. Additionally, the financial services business contributed to profit growth by significantly reducing funding costs through continuous optimization of its financing structure.
Comments